In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

HFA Career Cafe

New event at Heart Failure 2016: the HFA Career Cafe

In a relaxed atmosphere, with a cup of coffee or tea, young heart failure enthusiasts were given the opportunity to meet internationally renowned experts in the field.



This pilot event was a great success, many thanks to the Mentors and everyone who applied!

We look forward to renew this event at Heart failure 2017, applications will open in March 2017 (date to be confirmed).

 

What is the HFA Career Cafe?

The HFA Career Cafe is the meeting place for the future generation of heart failure specialists to interact with the great leaders of their specialty.

During individual interviews of 10 minutes, the selected applicants had the privilege to seek career development advice and recommendations from renowned professionals with years of successful careers behind them.

This is a unique platform where long-lasting generational relationships are possible!

Eligibility criteria

Applications are done online and are free. Applicants are asked to select the mentors they wish to meet in order of preference.

All applicants had to be registered to Heart Failure 2016 & 40 years of age or under

In total, 17 applicants were selected based on their motivations and CV. Each applicant was assigned up to 3 interviews.

Priority was given to HFA Gold and Silver Members. Become a member now.

THE 2016 mentors

Prof. Stefan D. Anker, FESC, FHFA (Göttingen, DE)

Area of expertise: heart failure, trials, pathophysiology, cachexia

Stefan D. Anker is Professor of Innovative Clinical Trials (W3) at University Medicine Göttingen (from September 2014).  Dr. Anker studied medicine at Charité Berlin and then started his clinical training in Germany completing it in the UK. He obtained his M.D. from Charité Medical School, Berlin, Germany (1993). He went on to earn a Ph.D. (1998) at the National Heart & Lung Institute of Imperial College London.  Dr Anker was Professor of Cardiology & Cachexia Research (W2) at Charité Berlin (2002-14). 

Dr. Anker has authored more than 600 original papers, reviews, and editorials that are well cited (total citations: >38,000, h-index: 96, papers with ≥ 200 citations: 46; source: Scopus, February 2016).  For his work Dr. Anker has won several prizes (including 2 AHA-YIAs), and has obtained a number of fellowships and grants, including 2 NIH grants, 2 EU-FP7 grants & 1 IMI/Horizon2020 grant.

Dr. Anker is Councillor of the Board European Society of Cardiology (ESC, 2014-16).  Dr. Anker serves in the board of the Heart Failure Association (HFA) of the ESC since 2006; he was HFA President (2012-14), and currently chairs the HFA committee on regulatory affairs.  Dr. Anker is founding Editor-in-Chief of the first open access heart failure journal ESC Heart Failure.  Dr. Anker serves on the editorial boards of 5 scientific journals (including European Heart Journal, European Journal of Heart Failure & IJC).

Dr. Anker was and is member of >25 international clinical trial steering committees, chairing or co-chairing several (incl. FAIR-HF & FAIR-HF2, TIM-HF, AUGMENT-HF, RESHAPE-HF2, IMPULSE-HF and BACH).  He served in a number of DMC’s (chairing 4) and end-point committees (chairing 4).    

Prof. Johann Bauersachs, FESC, FHFA (Hannover, DE)

Area of expertise: peripartum cardiomyopathy, aldosterone and mineralocorticoid receptor-mediated mechanisms and the role of non-coding RNAs.

Professor Johann Bauersachs is full professor and director of the Department of Cardiology and Angiology at Hannover Medical School since 2010. He is an interventional cardiologist with special interests in acute coronary syndromes, left ventricular healing and remodelling, acute and chronic heart failure, as well as intensive care. Professor Bauersachs is board certified in internal medicine, cardiology, interventional cardiology and intensive care.

Prof. Dirk L Brutsaert, EFESC (Kontich, BE)

Area of expertise: Myocardial and ventricular function (contraction, relaxation and filling, non-uniformity) in health and disease, in particular in heart failure, including the role of cardiac endothelium in endothelial-cardiomyocyte cell communication.

Dirk L Brutsaert is a Professor-Emeritus in the Departments of Cardiology and Pharmacology at the University of Antwerp. Between 1966 and 2002 he served as a Professor of Physiology and Medicine in the Department of Medicine at the University of Antwerp; from 1981 to 2002 he was Co-Chairman of the Department of Cardiology at University Hospital Antwerp; and he was an Honorary Consultant in the Department of Cardiology at AZ Middelheim Hospital, University of Antwerp, until 2006. Professor Brutsaert is Past President of the Heart Failure Association of the European Society of Cardiology (ESC) and of the Royal Academy of Medicine of Belgium (both 2004–2006).

Prof. Andrew Clark (Kingston Upon Thames, UK)

Area expertise:  exercise physiology, the possible role of oxygen therapy for heart failure and the natural history of heart failure.

Professor Andrew Clark is professor of clinical cardiology in the University of Hull. He was educated at Pembroke College, Cambridge, and trained in medicine at Westminster Medical School. He trained in heart failure at the National Heart and Lung Institute and Glasgow Western Infirmary. He has published widely on aspects of heart failure, and is co-editor of the Oxford Textbook of Heart Failure. He is the past Chair of the British Society for Heart Failure.

Prof. John Cleland, FESC (London, UK)

Area of expertise: heart failure, extending from its epidemiology and prevention, through the development and implementation of guidelines for the application of current knowledge, to large randomized trials. Particular current interests include the influence of myocardial and renal substrate on therapeutic response, novel methods of delivering care and theranostics. 

Prof. Arno W. Hoes, FESC, FHFA (Ultrecht, NL)

Arno W. Hoes studied medicine at the Catholic University Nijmegen. He obtained his PhD degree at the Erasmus University Rotterdam and was trained in Clinical Epidemiology at Erasmus Medical Center Rotterdam and the London School of Hygiene and Tropical Medicine.

In 1998 he was appointed professor of Clinical Epidemiology and General Practice at the Julius Center for Health Sciences and Primary Care of the University Medical Center in Utrecht. Since 2010, he is the Chair of the Julius Center.

His clinical research topics include the diagnosis, prognosis and therapeutic interventions in cardiovascular disease, and, in particular, heart failure. Many of his studies in heart failure are conducted in the primary care setting and focus on improving early diagnosis and prognosis of heart failure.

He is involved in many ESC activities and especially the HFA: he is the current treasurer of the HFA and chairs its Patient Care Committee. Professor Hoes has been (co-)applicant of many research grants. He has (co-)authored over 500 papers in peer-reviewed journals (Hirsch index 68) and approximately 50 PhD students completed their PhD thesis under his supervision.

Prof. Tiny Jaarsma, NFESC (Linjoping, SE)

Prof. Dr. Tiny Jaarsma (RN NFESC FAHA FAAN) is a professor in caring sciences/nursing science at the Faculty of Medicine and Health Sciences of the University of Linköping, Sweden. Her research focuses on the consequences of heart failure for patients and their families and developing and testing interventions to enhance their self-care. Her research has been published in over 300 publications ranging from short practical communications, book chapters to scientific publications in peer reviewed journals.

Tiny Jaarsma was trained as a nurse in Groningen, (NL) and she worked with cardiac patients since 1988, on the cardiology ward and in the Heart Failure clinic. She received her master degree from the University of Maastricht in 1992, as part of a nurse fellowship of the Netherlands Heart Foundation. She studied 6 months at the UCLA in 1993 with prof Dracup and completed her doctoral degree in 1999, with a thesis entitled “heart failure: nurses’ care”.

Currently she is the principle investigator of the ‘HF-WII’ study, an RCT on the effect of exergaming to increase physical activity in patients with heart failure. Her other research is aimed at improving communication between health care providers and patients regarding end of life issues (TALK-HF) Together with prof Anna Strömberg she is currently leading a research team with junior and senior researchers, international postdoc. She is the editor-in chief of the European Journal of Cardiovascular Nursing and the chair of the Science Committee of the ESC Council of Cardiovascular Nursing and Allied Professionals, involved in the Nursing Council of the AHA and is a former board member of the Heart Failure Association of the ESC. Professional activities include membership of national and international committees and guidelines (ESC, AHA), reviewer and member of editorial boards of peer-reviewed journals.

Prof. Michel Komajda, FESC (Paris, FR)

Area of expertise: pharmacology of heart failure, neuro-hormones in heart failure, genetics of dilated and hypertrophic cardiomyopathy.

Michel Komajda is the Head of the Department of Cardiology, Pitié Salpêtrière Hospital (Paris) and of the cardio-metabolic division (2006-2014). He is Professor of Cardiology at the University Pierre et Marie Curie - Paris VI since 1990. He is also member of the research Unit INSERM UMRS 1166, of the Institut Hospitalo-Universitaire ICAN and of the Academie Nationale de Medecine.  He is past President of the European Society of Cardiology (2012-2014), and did his term as President of this organization in 2010-2012. He occupied several key positions including Vice-President of the ESC Working Groups, Association and Councils (2006-2008), and Chairman of the ESC Programme Committee in 2005-2006 in the ESC. He was also Co-Chairman on the “Euro Heart Failure Survey I” and Member of the Executive Committee of “Euro Heart Failure Survey II” Programmes. He occupied the positions of Treasurer and General Secretary of the French Society of Cardiology and was President of this Society in 2002-2003. He is member of the Scientific Board of Acta Cardiologica, member of the Editorial Boards of European Heart Journal, European Journal of Heart Failure, Heart, and International Journal of Cardiology. Michel Komajda is the author of over 300 peer-reviewed papers, mostly in heart failure and has collaborated in several Steering and Executive Committees of international trials on heart failure and cardiovascular diseases (CARMEN, COMET, I-PRESERVE, HEAAL, RECORD, CORONA, SHIFT).

Prof. Christoph Maack, FHFA (Homburg, DE)

Area of expertise: pathophysiology and medical treatment of heart failure.

Christoph Maack is a Heisenberg Professor for Cardiovascular Physiology and Bioenergetics and a Senior Physician at the Department of Cardiology at the University of the Saarland in Homburg, Germany. His research focus is the pathophysiology and treatment of heart failure, with a special focus on the interplay between excitation-contraction coupling and mitochondrial energetics. Prof. Maack is a member of the HFA since 6 years and the Chair of the Basic and Translational Science section since 2 year.

Prof. John McMurray, FESC, FHFA (Glasgow,UK)

John McMurray BSc (Hons) MB ChB (Hons) MD FRCP FESC FACC FAHA FRSE FMedSci is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. He was the inaugural Eugene Braunwald Scholar in Cardiovascular (CV) Disease at the Brigham and Women’s Hospital, Boston, USA, and visiting Professor of Medicine, Harvard University, Boston, in 2010/2011 and is a Past-President of the Heart Failure Association of the European Society of Cardiology (ESC).

Professor McMurray’s primary research interest is in heart failure (HF) and his main research activity is clinical trials. He is, or was, the principal investigator, and member of the executive committee or steering committee in a number of large trials in HF, other CV diseases, renal disease and diabetes. Professor McMurray sits on the editorial board of the New England Journal of Medicine, as well as several leading CV journals, including the European Heart Journal and European Journal of Heart Failure. He has published approximately 600 original papers, reviews, and book chapters and is the primary author or editor of 13 books. Professor McMurray was included in the 2014 listing of Highly Cited Researchers by Thomson-Reuters.

Professor McMurray was the lead author of the World Health Organization and first Scottish Intercollegiate Guidelines Network Guidelines on the Management of HF. In addition he was a member of the 2008 ESC HF Guidelines Task Force, and Chair of the 2012 Task Force and member of the 2013 American College of Cardiology/American Heart Association HF Guidelines Committee and the 2014 National Institute for Health and Care Excellence (NICE) Acute HF Guideline Committee. He is a member of NICE Appraisal Committee A.

Prof. Theresa McDonagh, FESC, FHFA (London, UK)

Prof. McDonagh completed her general medical training in Edinburgh. She was then a Research Fellow in Cardiology at the Western Infirmary in Glasgow from 1991-1994 and a Lecturer at the CRI in Heart Failure, University of Glasgow (Honorary Senior Registrar) from 1994-1999. Working on the epidemiology of Left Ventricular Dysfunction and Natriuretic Peptides with Professor Henry J Dargie.

Subsequently she was appointed as a Senior Lecturer (Honorary Consultant Cardiologist) at the University of Glasgow and Glasgow Royal Infirmary where she ran the Heart Failure Service and was the Cardiologist involved in the Heart Transplant Programme (1999-2004). She was appointed as a Consultant Cardiologist with an Interest in Heart Failure at the Royal Brompton Hospital, London (2004-2011) before moving to King's College Hospital as a Consultant Cardiologist and Professor of Heart Failure.

Her research interests are in clinical heart failure in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers.

Prof. Alexandre Mebazaa FESC, FHFA (Paris, FR)

Prof. Alexandre Mebazaa is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France. Prof. Mebazaa qualified from the Louis Pasteur University, Strasbourg, France, and subsequently obtained a doctorate on the effect of endothelial cells on the calcium responsiveness of the cardiac myofilament from the Lariboisière School of Medicine, Paris. His research interests include mechanisms of contractile impairment during acute heart failure. He acted as member or Chair of several Steering Committee of agents tested in acute heart failure setting. He is also heavily involved in several European and global registries on circulatory failure. He authored or coauthored more than 300 papers and is Lead Editor of the “Acute Heart Failure” book. He is acting as Chair of Department of Anesthesiology and Critical Care in Paris

Prof. Christian Mueller, FESC (Basel, CH)

Area of expertise: early diagnosis and management of patients with acute heart failure; early diagnosis and management of patients with acute myocardial infarction; and improving patient care by integrating novel biochemical and electrocardiographic signatures.

Dr. Mueller is a clinical cardiologist at the University Hospital Basel. He is professor of cardiology, internal medicine and intensive care medicine at Basel University and head of the Cardiovascular Research Institute Basel (CRIB).

Prof. Piotr Ponikowski, FESC, FHFA (Wroclaw, PL)

Prof. Ponikowski is currently Head of Department of Heart Diseases at Wroclaw Medical University and Head of Cardiology Department at the Military Hospital in Wroclaw. He holds a MD and a PhD from Wroclaw Medical University. He is a world recognized expert in the field of heart failure, he is member of the Committee for Practice Guidelines and chairperson of new ESC guidelines HF 2016. He has been involved in European Society of Cardiology activities since 1998, when he was elected as a Fellow (FESC). He acted as Past-President of Heart Failure Association of the ESC in the years 2010-12. He is the author of more than 500 publications which are well cited (h-index-75). He has been a principal investigator in more than 70 clinical trials, and a member of executive/steering committees in more than 20 clinical trials.

Prof. Jillian Riley, NFESC, FHFA (London, UK)

Dr Jillian Riley is a lecturer at the National Heart and Lung Institute, Imperial College. She directed studies in Cardio respiratory Nursing at the college for ten years before deciding to concentrate on supporting health professionals more widely to deliver high quality patient care.

With a particular interest in supporting the delivery of cardiac care Dr Riley was involved in the development of the UK National Service Framework for Coronary Heart Disease. Subsequently she was instrumental in the development of the British Association for Nursing in Cardiac Care (BANCC), an affiliated group to the British Cardiovascular Society, and was President of BANCC until 2003. Jill has served on a number of expert committees both nationally and internationally. Currently she sits on the Executive committee of the board of the European Heart Failure Association of the ESC. Dr Riley also reviews the evidence on the organisation of care and monitoring for the NHS evidence update on Heart Failure and sits on the cardiovascular strategic leadership group for NHS London where she co-chairs the heart failure subgroup.

Dr Riley has co-authored a text on cardiothoracic nursing and contributed to a number of other text books and publications. She is an associate editor for the European Journal of Heart Failure and sits on the editorial board of the European Journal of Cardiovascular Nursing and on the British Journal of Cardiac Nursing.

Prof. Karen Sliwa-Hahnle, FESC (Cape Town, SA)

Area of expertise: cardiovascular disease in pregnancy and postpartum is one of her main areas of clinical and pathophysiological research

Prof. Karen Sliwa, MD, PhD, FESC, FACC, DTM & H- is the Director of the Hatter Institute for Cardiovascular Research in Africa University of Cape Town, South Africa. Recent progress in understanding underlying pathophysiology of Peripartum Cardiomyopathy, enabled by novel experimental approaches interlinked with unique international efforts has led to great progress in awareness and management of the disease. In order to coordinate efforts even better, a Study Group, ‘Peripartum Cardiomyopathy’, of the Heart Failure Association of the European Cardiac Society, chaired by her and others was formed in 2009. That has led to a large international registry under the EuroObservational Programe on Peripartum Cardiomyopathy.

In recognition of her work Prof Sliwa has received several awards, including the South Africa/Germany Year of Science Celebrations Award (2012), German Cardiac Society Paul Morawitz Award for Exceptional Cardiovascular Research (2013) and the CPP award (2014) and the Africa’s most influential women in Business & Government life-time award (2015).

Prof. Karl Swedberg, FESC (Gothenburg, SW)

Karl Swedberg is Senior Professor of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden and Professor of Cardiology, National Heart and Lung Institute, Imperial College, London. His research interests include beta-blockers and angiotensin-converting enzyme inhibitors (ACEIs) and their effects on heart failure (HF) and myocardial infarction (MI), neuroendocrine activation in HF and the treatment of chronic HF. Professor Swedberg was the first to report on the survival benefits of a beta-blocker (1979), ACEI (1987) and angiotensin receptor blocker (2003) in chronic HF. He has published widely, including over 320 original research papers and 25 textbook chapters. In addition, he has been a steering committee member for numerous outcome trials in HF and MI and is a member of the Executive Committee for the PARADIGM-HF trial.

Professor Swedberg received the 2004 Kaufman Award from Cleveland Clinics (USA) for his HF research and the European Society of Cardiology Gold Medal 2007 for his outstanding contributions to the cardiovascular field. He has been an Honorary Member of the Thai Heart Association since 2007, the Swedish Society of Cardiology since 2008, and the Japan Circulatory Society since 2009. In addition, Professor Swedberg was Editor-in-Chief of European Journal of Heart Failure from 2005 to 2009. He is associate Editor of the European Heart Journal since 2012.